KEY PRODUCTS
With Fermion, start the journey of your innovative API.
01 1Fermion Oy
01 1GLIPIZIDE
01 1Finland
01 1Active
01 1Complete
With Fermion, start the journey of your innovative API.
GDUFA
DMF Review : Complete
Rev. Date : 2020-06-12
Pay. Date : 2020-06-05
DMF Number : 15174
Submission : 2000-12-04
Status : Active
Type : II
20
Fermion Oy, based in Finland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for With Fermion, start the journey of your innovative API.
One of their notable products is GLIPIZIDE, with a corresponding US DMF Number 15174.
Remarkably, this DMF maintains an Active status since its submission on December 04, 2000, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 12, 2020, and payment made on June 05, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
